Acute high dose of chlorpyrifos alters performance of rats in the elevated plus-maze and the elevated T-maze

NeuroToxicology

Volumn 30, Issue 6, 2009, Pages 1025-1029

  Lopez Crespo G A ^a   Flores, P ^b   Sanchez Santed F ^b   Sanchez Amate M C ^b  

^a UNIVERSITY OF MURCIA   (Spain)

^b UNIVERSITY OF ALMERÍA   (Spain)

Author keywords

Chlorpyrifos; Elevated plus maze; Elevated T maze; Time dependent effects

Indexed keywords

CHLORPYRIFOS;

ACUTE DRUG ADMINISTRATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; EMOTIONALITY; ESCAPE BEHAVIOR; MALE; MAZE TEST; NEUROCHEMISTRY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; TASK PERFORMANCE;

ANALYSIS OF VARIANCE; ANIMALS; CHLORPYRIFOS; CHOLINESTERASE INHIBITORS; ESCAPE REACTION; MALE; MAZE LEARNING; RATS; RATS, WISTAR; REACTION TIME; TIME FACTORS;

ANIMALIA; FICUS OBTUSIFOLIA; OZOPHORA (BUG); RATTUS;

EID: 71049179051     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2009.07.009     Document Type: Article

References (39)

1. Abou-Donia M.B. Organophosphorus ester-induced chronic neurotoxicity. Arch Environ Health 58 (2003) 484-497
2. Aldridge J.E., Levin E.D., Seidler F.J., and Slotkin T.E. Developmental exposure of rats to chlorpyrifos leads to behavioral alterations in adulthood, involving serotoninergic mechanisms and resembling animal models of depression. Environ Health Perspect 113 (2005) 527-531
3. Aldridge J.E., Seidler F.J., and Slotkin T.E. Developmental exposure to chlorpyrifos elicits sex-selective alterations of serotoninergic synaptic function in adulthood: critical periods and regional selectivity for effects on the serotonin transporter, receptor subtypes, and cell signalling. Environ Health Perspect 112 (2004) 148-155
4. Bushnell P.J., Pope C.N., and Padilla S. Behavioral and neurochemical effects of acute chlorpyrifos in rats: tolerance to prolonged inhibition of cholinesterase. J Pharmacol Exp Ther 266 (1993) 1007-1017
5. Cardona D., López-Grancha M., López-Crespo G., Nieto-Escamez F., Sánchez-Santed F., and Flores P. Vulnerability of long-term neurotoxicity of chlorpyrifos: effect on schedule-induced polydipsia and a delay discounting task. Psychopharmacology (Berl) 189 (2006) 47-57
6. Carvajal F., López-Grancha M., Navarro M., Sánchez-Amate M.C., and Cubero I. Long-lasting reductions of ethanol drinking, enhanced ethanol-induced sedation, and decreased c-fos expression in the Edinger-Westphal nucleus in Wistar rats exposed to the organophosphate chlorpyrifos. Toxicol Sci 96 (2007) 210-220
7. Carvajal F., Sánchez-Amate M.C., Sánchez-Santed F., and Cubero I. Neuroanatomical targets of the organophosphate chlorpyrifos by c-fos immunolabeling. Toxicol Sci 84 (2005) 360-367
8. Dam K., Garcia S.J., Seidler F.J., and Slotkin T.A. Neonatal chlorpyrifos exposure alters synaptic development and neuronal activity in cholinergic and catecholaminergic pathways. Dev Brain Res 116 (1999) 9-20
9. Dawson G.R., and Tricklebank M.D. Use of the elevated plus maze in the search for novel anxiolytic agents. Trends Pharmacol Sci 16 2 (1995) 33-36
10. Graeff F.G., Ferreira Netto C., and Zangrossi H. The elevated T-maze as an experimental model of anxiety. Neurosci Biobehav Rev 23 (1998) 237-246
11. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 54 (1996) 21-30
12. Kalin N.H., Shelton S.E., and Davidson R.J. The role of the central nucleus of the amygdala in mediating fear and anxiety in the primate. J Neurosci 24 June (24) (2004) 5506-5515
13. Karanth S., Liu J., Mirajkar N., and Pope C. Effects of acute chlorpyrifos exposure on in vivo acetylcholine accumulation in rat striatum. Toxicol Appl Pharmacol 216 1 (2006) 150-156
14. López-Crespo G., Carvajal F., Flores P., Sánchez-Santed F., and Sánchez-Amate M.C. Time-course of biochemical and behavioural effects of a single high dose of chlorpyrifos. Neurotoxicology 28 (2007) 541-547
15. López-Grancha M., Sánchez-Amate M.C., Navarro M., Carvajal F., Sánchez-Santed F., and Cubero I. Lateral parabrachial lesions disrupt paraoxon-induced conditioned flavor avoidance. Toxicol Sci 91 (2006) 210-217
16. McNaughton N., and Zangrossi Jr. H. Theoretical approaches to the modelling of anxiety in animals. In: Blanchard R.J., Blanchard C., Griebel G., and Nutt D.J. (Eds). Handbook of anxiety and fear (2008), Elsevier, Netherlands 11-28
17. Menard J., and Treit D. Lateral and medial septal lesions reduce anxiety in the plus-maze and probe-burying tests. Physiol Behav 60 3 (1996) 845-853
18. Millan M.J. The neurobiology and control of anxious states. Prog Neurobiol 70 (2003) 83-244
19. Moreno M., Cañadas F., Cardona D., Suñol C., Campa L., Sánchez-Amate M.C., Flores P., and Sánchez-Santed F. Long-term monoamine changes in the striatum and nucleus accubemns after acute chlorpyrifos exposure. Toxicol Lett 176 (2008) 162-167
20. Olausson P., Akesson P., Engel J.A., and Söderpalm B. Effects of 5-HT1A and 5-HT2 receptor agonists on the behavioral and neurochemical consequences of repeated nicotine treatment. Eur J Pharmacol 420 1 (2001) 45-54
21. Olausson P., Akesson P., Petersson A., Engel J.A., and Söderpalm B. Behavioral and neurochemical consequences of repeated nicotine treatment in the serotonin-depleted rat. Psychopharmacology (Berl) 155 4 (2001) 348-361
22. Pellow S., and File S.E. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 24 (1986) 525-529
23. Poltronieri S.C., Zangrossi Jr. H., and Viana M.B. Antipanic-like effect of serotonin reuptake inhibition in the elevated T-maze. Behav Brain Res 147 (2003) 185-192
24. Pope C.N. Organophosphorus pesticides: do they all have the same mechanism of toxicity?. J Toxicol Environ Health B 2 (1999) 161-181
25. Ray D.E., and Richards P.G. The potential for toxic effects of chronic, low-dose exposure to organophospates. Toxicol Lett 120 (2001) 343-351
26. Raines K.W., Seidler F.J., and Slotkin T.A. Alterations in serotonin transporter expression in brain regions of rats exposed neonatally to chlorpyrifos. Dev Brain Res 130 (2001) 65-72
27. Richardson R.J. Assessment of the neurotoxic potential of chlorpyrifos relative of other organophosphorus compounds: a critical review of the literature. J Toxicol Environ Health 44 (1995) 135-165
28. Rodgers R.J., Cao B.J., Dalvi A., and Holmes A. Animal models of anxiety: an ethological perspective. Braz J Med Biol Res 30 (1997) 289-304
29. Rodgers R.J., and Dalvi A. Anxiety, defence and the elevated plus-maze. Neurosci Biobehav Rev 21 6 (1997) 801-810
30. Sánchez-Amate M.C., Dávila E., Cañadas F., Flores P., and Sánchez-Santed F. Chlorpyrifos shares stimulus properties with pentilenetetrazol as evaluated by and operant drug discrimination task. Neurotoxicology 23 (2002) 795-803
31. Sánchez-Amate M.C., Flores P., and Sánchez-Santed F. Effects of chlorpyrifos in the plus-maze model of anxiety. Behav Pharmacol 12 (2001) 285-292
32. Slotkin T.A. Guidelines for developmental neurotoxicity and their impact on organophosphates pesticides: a personal view from an academic perspective. Neurotoxicology 25 (2004) 631-640
33. Soubrié P. Reconciling the role of central serotonin neurons in human and animal behavior. Behav Brain Sci 9 (1986) 319-364
34. Texeira R.C., Zangrosi Jr. H., and Graeff F.G. Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety. Pharmacol Biochem Behav 65 (2000) 571-576
35. Treit D., and Menard J. Dissociations among the anxiolytic effects of septal, hippocampal, and amygdaloid lesions. Behav Neurosci 111 3 (1997) 653-658
36. Treit D., and Menard J. Effects of centrally administered anxiolytic compounds in animal models of anxiety. Neurosci Biobehav Rev 23 4 (1999) 591-613
37. Won Y.K., Liu J., Olivier K., Zheng Q., and Pope C.N. Age-related effects of chlorpyrifos on acetylcholine release in rat brain. Neurotoxicology 22 (2001) 39-48
38. Zangrossi H., and Graeff F.G. Behavioral validation of the elevated T-maze, a new animal model of anxiety. Brain Res Bull 44 (1997) 1-5
39. Zanoveli J.M., Nogueira R.L., and Zangrossi Jr. H. Chronic imipramine treatment sensitize 5-HT1A and 5-HT2A receptors in the dorsal periaqueductal gray matter: evidences from the elevated T-maze test of anxiety. Behav. Pharmacol 16 (2005) 543-552